Effect of Thyroid Hormone on Uncoupling Protein-3 mRNA Expression in Rat Heart and Skeletal Muscle

Thyroid

Volumn 14, Issue 3, 2004, Pages 177-185

  Queiroz, Marcia Silva ^a   Shao, Yvonne ^a   Ismail Beigi, Faramarz ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CLENBUTEROL; LIOTHYRONINE; MESSENGER RNA; PROPRANOLOL; UNCOUPLING PROTEIN 3;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; HEART MUSCLE; HEART VENTRICLE; HORMONAL REGULATION; HYPERTHYROIDISM; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SKELETAL MUSCLE; SOLEUS MUSCLE;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BODY WEIGHT; CAPTOPRIL; CARRIER PROTEINS; CLENBUTEROL; DRUG SYNERGISM; HYPERTHYROIDISM; ION CHANNELS; MALE; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; MYOCARDIUM; ORGAN SIZE; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRIIODOTHYRONINE;

EID: 1842534255     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072504773297849     Document Type: Article

References (60)

1. Levey GS, Klein I 1990 Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 88:642-646.
2. Klein I 1988 Thyroxine-induced cardiac hypertrophy: Time course of development and inhibition by propranolol. Endocrinology 123:203-210.
3. Hauger-Klevene JH, Brown H, Zavaleta J 1972 Plasma renin activity in hyper- and hypothyroidism: Effect of adrenergic blocking agents. J Clin Endocrinol Metab 34:625-629.
4. Kobori H, Ichihara A, Suzuki H, Takenaka T, Miyashita Y, Hayashi M, Saruta T 1997 Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. Am J Physiol 273:H593-H599.
5. Klein I 1990 Thyroid hormone and the cardiovascular system. Am J Med 88:631-637.
6. Morgan HE, Baker KM 1991 Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation 83:13-25.
7. Mano T, Sakamoto H, Fujita K, Makino M, Kakizawa H, Nagata M, Kotake M, Hamada M, Uchimura K, Hayakawa N, Hayashi R, Nakai A, Itoh M, Kuzuya H, Nagasaka A 1998 Effects of thyroid hormone on catecholamine and its metabolite concentrations in rat cardiac muscle and cerebral cortex. Thyroid 8:353-358.
8. 3 potentiates the adrenergic stimulation of type II 5′-deiodinase activity in cultured rat brown adipocytes. Am J Physiol 271:E15-E23.
9. Franklyn JA, Wilkins MR, Wilkinson R, Ramsden DB, Sheppard MC 1985 The effect of propranolol on circulating thyroid hormone measurements in thyrotoxic and euthyroid subjects. Acta Endocrinol (Copenh) 108:351-355.
10. Jones MK, John R, Jones GR 1980 The effect of oxprenolol, acebutolol and propranolol on thyroid hormones in hyperthyroid subjects. Clin Endocrinol (Oxf) 13:343-347.
11. Riddell JG, Neill JD, Kelly JG, McDevitt DG 1980 Effects of thyroid dysfunction on propranolol kinetics. Clin Pharmacol Ther 28:565-574.
12. Feely J, Forrest A, Gunn A, Hamilton W, Stevenson I, Crooks J 1980 Propranolol dosage in thyrotoxicosis. J Clin Endocrinol Metab 51:658-661.
13. Baldwin KM, Ernst SB, Herrick RE, Hooker AM, Mullin WJ 1980 Exercise capacity and cardiac function in trained and untrained thyroid-deficient rats. J Appl Physiol 49: 1022-1026.
14. Baldwin KM, Hooker AM, Herrick RE, Schrader LF 1980 Respiratory capacity and glycogen depletion in thyroid-deficient muscle. J Appl Physiol 49:102-106.
15. Fitts RH, Winder WW, Brooke MH, Kaiser KK, Holloszy JO 1980 Contractile, biochemical, and histochemical properties of thyrotoxic rat soleus muscle. Am J Physiol 238:C14-C20.
16. Caiozzo VJ, Herrick RE, Baldwin KM 1991 Influence of hyperthyroidism on maximal shortening velocity and myosin isoform distribution in skeletal muscles. Am J Physiol 261:C285-C295.
17. Fitzsimons DP, Herrick RE, Baldwin KM 1990 Isomyosin distributions in rodent muscles: Effects of altered thyroid state. J Appl Physiol 69:321-327.
18. Boss O, Hagen T, Lowell BB 2000 Uncoupling proteins 2 and 3: Potential regulators of mitochondrial energy metabolism. Diabetes 49:143-156.
19. Himms-Hagen J 1989 Role of thermogenesis in the regulation of energy balance in relation to obesity. Can J Physiol Pharmacol 67:394-401.
20. Silva JE, Rabelo R 1997 Regulation of the uncoupling protein gene expression. Eur J Endocrinol 136:251-264.
21. Lowell BB, Spiegelman BM 2000 Towards a molecular understanding of adaptive thermogenesis. Nature 404:652-660.
22. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, Warden CH 1997 Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia. Nat Genet 15:269-272.
23. Gong DW, He Y, Karas M, Reitman M 1997 Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin. J Biol Chem 272:24129-24132.
24. Silva JE 1988 Full expression of uncoupling protein gene requires the concurrence of norepinephrine and triiodothyronine. Mol Endocrinol 2:706-713.
25. Boss O, Samec S, Kuhne F, Bijlenga P, Assimacopoulos-Jeannet F, Seydoux J, Giacobino JP, Muzzin P 1998 Uncoupling protein-3 expression in rodent skeletal muscle is modulated by food intake but not by changes in environmental temperature. J Biol Chem 273:5-8.
26. Boss O, Samec S, Dulloo A, Seydoux J, Muzzin P, Giacobino JP 1997 Tissue-dependent upregulation of rat uncoupling protein-2 expression in response to fasting or cold. FEBS Lett 412:111-114.
27. Millet L, Vidal H, Andreelli F, Larrouy D, Riou JP, Ricquier D, Laville M, Langin D 1997 Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J Clin Invest 100:2665-2670.
28. Weigle DS, Selfridge LE, Schwartz MW, Seeley RJ, Cummings DE, Havel PJ, Kuijper JL, BeltrandelRio H 1998 Elevated free fatty acids induce uncoupling protein 3 expression in muscle: A potential explanation for the effect of fasting. Diabetes 47:298-302.
29. Nagase I, Yoshida T, Saito M 2001 Up-regulation of uncoupling proteins by beta-adrenergic stimulation in L6 myotubes. FEBS Lett 494:175-180.
30. Viengchareun S, Penfornis P, Zennaro MC, Lombes M 2001 Mineralocorticoid and glucocorticoid receptors inhibit UCP expression and function in brown adipocytes. Am J Physiol Endocrinol Metab 280:E640-E649.
31. Queiroz MS, Shao Y, Ismail-Beigi F 2002 Effect of thyroid hormone on the abundance of UCP-mRNA in rat heart and skeletal muscle. FASEB J 16:A1117.
32. Somjen D, Ismail-Beigi F, Edelman IS 1981 Nuclear binding of T3 and effects of QO2, Na-K-ATPase, and alpha-GPDH in liver and kidney. Am J Physiol 240:E146-E154.
33. +-ATPase activity in rat liver. Proc Soc Exp Biol Med 146:983-988.
34. Oppenheimer JH 1983 The nuclear receptor-triiodothyronine complex: Relationship to thyroid hormone distribution, metabolism, and biological action. In: Oppenheimer JH, Samuels HH (eds) Molecular Basis of Thyroid Hormone Action. Academic Press, New York, p. 498.
35. Culmsee C, Stumm RK, Schafer MK, Weihe E, Krieglstein J 1999 Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur J Pharmacol 379:33-45.
36. McElroy JF, O'Donnell JM 1988 Discriminative stimulus properties of clenbuterol: evidence for beta adrenergic involvement. J Pharmacol Exp Ther 245:155-163.
37. Moore NG, Pegg GG, Sillence MN 1994 Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration. Am J Physiol 267:E475-E484.
38. von Deutsch DA, Abukhalaf IK, Wineski LE, Aboul-Enein HY, Pitts SA, Parks BA, Oster RA, Paulsen DF, Potter DE 2000 Beta-agonist-induced alterations in organ weights and protein content: Comparison of racemic clenbuterol and its enantiomers. Chirality 12:637-648.
39. Ishac EJ, Eskay R, Hirata F, Axelrod J, Kunos G 1987 Adrenergic regulation of beta-endorphin secretion from anterior pituitary in conscious rats: Effects of thyroid state. Endocrinology 120:1073-1078.
40. van Hardeveld C, Zuidwijk MJ, Kassenaar AA 1979 Studies on the origin of altered thyroid hormone levels in the blood of rats during cold exposure. II. Effect of propranolol and chemical sympathectomy. Acta Endocrinol (Copenh) 91: 484-492.
41. Evered MD, Robinson MM 1984 Increased or decreased thirst caused by inhibition of angiotensin-converting enzyme in the rat. J Physiol 348:573-588.
42. Levens NR, Peach MJ, Vanghan ED, Jr., Weed WC, Carey RM 1981 Responses of blood pressure and angiotensin-converting enzyme activity to acute captopril administration in normotensive and hypertensive rats. Endocrinology 108:536-544.
43. Lopez-Sela P, Brime JI, Diaz F, Marin B, Costales M, Vijande M 1989 Effects of inhibitors of the renin-angiotensin system on water intake after insulin administration. Appetite 13:143-154.
44. Sharma JN, Stewart JM, Mohsin SS, Katori M, Vavrek R 1992 Influence of a kinin antagonist on acute hypotensive responses induced by bradykinin and captopril in spontaneously hypertensive rats. Agents Actions Suppl 38(Pt 3):258-269.
45. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
46. Thomas PS 1980 Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77:5201-5205.
47. +. Am J Physiol 255:C252-C260.
48. Chaudhury S, Ismail-Beigi F, Gick GG, Levenson R, Edelman IS 1987 Effect of thyroid hormone on the abundance of Na,K-adenosine triphosphatase alpha-subunit messenger ribonucleic acid. Mol Endocrinol 1:83-89.
49. Brent GA 29-9-1994 The molecular basis of thyroid hormone action. N Engl J Med 331:847-853.
50. Buccino RA, Spann JF, Jr, Pool PE, Sonnenblick EH, Braunwald E 1967 Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium. J Clin Invest 46:1669-1682.
51. Dillmann WH 1990 Biochemical basis of thyroid hormone action in the heart. Am J Med 88:626-630.
52. Gick GG, Melikian J, Ismail-Beigi F 1990 Thyroidal enhancement of rat myocardial Na,K-ATPase: Preferential expression of alpha 2 activity and mRNA abundance. J Membr Biol 115:273-282.
53. Shao Y, Ojamaa K, Klein I, Ismail-Beigi F 2000 Thyroid hormone stimulates Na, K-ATPase gene expression in the hemodynamically unloaded heterotopically transplanted rat heart. Thyroid 10:753-759.
54. Dunn FG, Oigman W, Ventura HO, Messerli FH, Kobrin I, Frohlich ED 1984 Systemic and renal effects of enalapril and its effects on cardiac mass. J Hypertens Suppl 2:S57-S61.
55. Lanni A, De Felice M, Lombardi A, Moreno M, Fleury C, Ricquier D, Goglia F 1997 Induction of UCP2 mRNA by thyroid hormones in rat heart. FEBS Lett 418:171-174.
56. Masaki T, Yoshimatsu H, Kakuma T, Hidaka S, Kurokawa M, Sakata T 1997 Enhanced expression of uncoupling protein 2 gene in rat white adipose tissue and skeletal muscle following chronic treatment with thyroid hormone. FEBS Lett 418:323-326.
57. Larkin S, Mull E, Miao W, Pittner R, Albrandt K, Moore C, Young A, Denaro M, Beaumont K 1997 Regulation of the third member of the uncoupling protein family, UCP3, by cold and thyroid hormone. Biochem Biophys Res Commun 240:222-227.
58. Nakamura Y, Nagase I, Asano A, Sasaki N, Yoshida T, Umekawa T, Sakane N, Saito M 2001 Beta 3-adrenergic agonist up-regulates uncoupling proteins 2 and 3 in skeletal muscle of the mouse. J Vet Med Sci 63:309-314.
59. Ricquier D, Bouillaud F, Toumelin P, Mory G, Bazin R, Arch J, Penicaud L 1986 Expression of uncoupling protein mRNA in thermogenic or weakly thermogenic brown adipose tissue. Evidence for a rapid beta-adrenoreceptor-mediated and transcriptionally regulated step during activation of thermogenesis. J Biol Chem 261:13905-13910.
60. Rajab P, Fox J, Riaz S, Tomlinson D, Ball D, Greenhaff PL 2000 Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat. Am J Physiol Regul Integr Comp Physiol 279:R1076-R1081.